ArticleProceedings of the National Academy of Sciences of the United States of America2026

A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance.

Vasiliki Liaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.